This affiliation gives us access to a variety of oncology trials offered through the Cancer Trials Support Unit (CTSU). Through this site, many trials are available to our patients. The CTSU is a project sponsored by the National Cancer Institute (NCI) for the support of a national network of physicians to participate in the NCI sponsored Phase III cancer treatment trials.
- Breast cancer.
- Gastrointestinal cancers.
- Genitourinary cancers.
- Gynecological cancers.
- Head and neck cancers.
- Metastatic cancer.
For information regarding these trials, or other trials that may be available, please contact Jane White, at (401) 737-7010 ext. 31503, or Patti Wingate at (401) 737-7010 ext. 31857.
Kent Hospital's Cancer Program participates in a number of clinical research trials through the Cancer Registry, offering cutting edge treatments to our patients. The Cancer Registry maintains a database, allowing us to track disease characteristics and treatments. Our program is accredited with commendation by the American College of Surgeons Commission on Cancer, as a Community Hospital Cancer Program. Please visit the COC for further information on accreditation and how it benefits our cancer program.